000 01448 a2200469 4500
005 20250518072512.0
264 0 _c20201103
008 202011s 0 0 eng d
022 _a2045-2322
024 7 _a10.1038/s41598-019-53093-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGastine, Silke
245 0 0 _aPharmacokinetics of Micafungin in Critically Ill Patients.
_h[electronic resource]
260 _bScientific reports
_c11 2019
300 _a17741 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntifungal Agents
_xpharmacokinetics
650 0 4 _aCandida albicans
_xdrug effects
650 0 4 _aCandida glabrata
_xdrug effects
650 0 4 _aCandida parapsilosis
_xdrug effects
650 0 4 _aCandidiasis
_xblood
650 0 4 _aCritical Illness
650 0 4 _aDrug Monitoring
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMicafungin
_xpharmacokinetics
650 0 4 _aMiddle Aged
650 0 4 _aYoung Adult
700 1 _aLanckohr, Christian
700 1 _aBlessou, Magalie
700 1 _aHorn, Dagmar
700 1 _aFobker, Manfred
700 1 _aBause, Daniela
700 1 _aHempel, Georg
700 1 _aEllger, Björn
773 0 _tScientific reports
_gvol. 9
_gno. 1
_gp. 17741
856 4 0 _uhttps://doi.org/10.1038/s41598-019-53093-6
_zAvailable from publisher's website
999 _c30365273
_d30365273